MACCARONI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 2.783
EU - Europa 1.278
AS - Asia 989
SA - Sud America 188
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.327
Nazione #
US - Stati Uniti d'America 2.743
SG - Singapore 322
IT - Italia 290
CN - Cina 229
RU - Federazione Russa 175
VN - Vietnam 162
UA - Ucraina 157
BR - Brasile 148
DE - Germania 122
SE - Svezia 108
IE - Irlanda 94
TR - Turchia 71
FI - Finlandia 62
HK - Hong Kong 62
DK - Danimarca 61
FR - Francia 61
GB - Regno Unito 55
CI - Costa d'Avorio 38
IN - India 34
KR - Corea 32
PL - Polonia 25
BD - Bangladesh 21
MA - Marocco 21
CA - Canada 20
NL - Olanda 17
AR - Argentina 15
JP - Giappone 14
MX - Messico 14
ZA - Sudafrica 14
BE - Belgio 11
ES - Italia 10
EC - Ecuador 7
CO - Colombia 6
CZ - Repubblica Ceca 5
PH - Filippine 5
PK - Pakistan 5
AT - Austria 4
IQ - Iraq 4
RO - Romania 4
CL - Cile 3
DZ - Algeria 3
ID - Indonesia 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
SA - Arabia Saudita 3
SC - Seychelles 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.327
Città #
Ashburn 463
Chandler 256
Singapore 204
San Jose 178
Jacksonville 169
Fairfield 164
Dallas 122
Dublin 94
Boardman 88
New York 87
Wilmington 86
Ann Arbor 79
Woodbridge 74
Beijing 69
Centro 69
Houston 65
Seattle 62
Hong Kong 58
Los Angeles 58
Cambridge 55
Hanoi 49
Ho Chi Minh City 48
Moscow 46
Des Moines 40
Abidjan 38
Munich 38
Lawrence 36
Princeton 36
San Mateo 35
The Dalles 33
Lauterbourg 31
Turin 29
Orem 24
Turku 24
Warsaw 24
Chicago 21
Ancona 19
Buffalo 18
Hefei 15
San Diego 15
Santa Clara 14
Helsinki 12
London 12
Tokyo 12
Johannesburg 11
Rome 11
Brussels 10
Pune 10
São Paulo 10
Atlanta 9
Brooklyn 9
Amsterdam 8
Montreal 8
Poplar 8
Salt Lake City 8
Chennai 7
Da Nang 7
Washington 7
Cagliari 6
Canicattì 6
Council Bluffs 6
Mexico City 6
Rio de Janeiro 6
Stockholm 6
Boston 5
Elk Grove Village 5
Falconara Marittima 5
Florence 5
Guangzhou 5
Manchester 5
Marche 5
Milan 5
New Delhi 5
Olomouc 5
Paris 5
Wuxi 5
Bari 4
Brasília 4
Columbus 4
Curitiba 4
Denver 4
Frankfurt am Main 4
Haiphong 4
Jiaxing 4
Modena 4
Mumbai 4
New Bedfont 4
Phoenix 4
Shanghai 4
Sterling 4
Tampa 4
Thái Nguyên 4
Wuhan 4
Amman 3
Belo Horizonte 3
Birmingham 3
Biên Hòa 3
Dhaka 3
Hải Dương 3
Isernia 3
Totale 3.477
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 216
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 195
Caratterizzazione istologica e molecolare nelle pazienti con carcinoma ovarico sporadico ed ereditario 194
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 187
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 183
Optimal management of resected gastric cancer 181
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. 178
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 173
5-Fluorouracil pharmacogenomics: still rocking after all these years? 170
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 167
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 166
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 163
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 162
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy. 161
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 154
Adjuvant treatment after surgical resection 154
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 142
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 142
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 140
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2. 139
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 139
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 136
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 135
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 132
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 130
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 128
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 127
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 126
Transient sunitinib resistance in gastrointestinal stromal tumors. 125
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 123
Locally advanced rectal cancer: new findings in anticancer therapy 108
Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1. 107
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 106
Thymic epithelial tumors (TETs) and additional tumors: a single Centre experience 102
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 97
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 80
Totale 5.406
Categoria #
all - tutte 23.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 49 37
2021/2022309 25 77 9 5 1 15 16 22 14 41 19 65
2022/2023697 51 93 50 54 51 101 1 45 146 6 84 15
2023/2024380 57 8 26 45 51 105 4 13 1 8 7 55
2024/2025712 102 56 14 11 45 23 78 31 108 53 104 87
2025/20262.031 196 127 134 213 300 153 331 191 160 179 47 0
Totale 5.406